Skip to main content

Table 2 Summary of composition and coverage of medicine price basket by medicine category (%), average from 2010 to 2014

From: How well does Malaysia achieve value for money in public sector purchasing of medicines? Evidence from medicines procurement prices from 2010 to 2014

WHO ATC level 1 category

Share of medicine formulations in basket (%)

Share of expenditure in basket (%)

Expenditure of medicines in basket as a percentage of total purchases by medicine category (%)

A – Alimentary tract and metabolism

15.1

39.6

58.9

B – Blood and blood forming organs

2.2

1.0

4.2

C – Cardiovascular system

16.0

17.7

27.4

D – Dermatalogicals

4.4

0.5

25.6

G – Genito-urinary system and sex hormones

2.0

0.5

3.5

H - Systemic hormonal preparations, excluding sex hormones and insulins

4.5

2.2

40.2

J – Antiinfectives for systemic use

27.1

21.5

29.1

L – Antineoplastic agents and immunomodulating agents

2.1

1.3

2.8

M – Musculo-skeletal system

3.7

1.2

10.9

N – Nervous system

11.2

8.9

19.1

P – Antiparasitic products, insecticides and repellents

0.9

0.2

8.2

R – Respiratory system

6.7

4.8

19.1

S – Sensory organs

4.0

0.7

12.1

V – Various

  

Total

100.00

100.00